Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA-Reference-Cited by-同舟云学术

Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA

Published:2017-01 Issue:1 Volume:72 Page:23-32
ISSN:0009-9260
Container-title:Clinical Radiology
language:en
Short-container-title:Clinical Radiology

Author:

De Visschere P.,Lumen N.,Ost P.,Decaestecker K.,Pattyn E.,Villeirs G.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference34 articles.

1. Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard;Abd-Alazeez;Prostate Cancer Prostatic Dis,2014

2. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study;Thompson;J Urol,2014

3. Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric study;Renard-Penna;World J Urol,2015

4. How good is MRI at detecting and characterising cancer within the prostate?;Kirkham;Eur Urol,2006

5. The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—can it rule out clinically significant prostate cancer?;Abd-Alazeez;Urol Oncol,2014

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparisons of three scoring systems based on biparametric magnetic resonance imaging for prediction of clinically significant prostate cancer;Prostate International;2024-08

2. Japanese clinical practice guidelines for prostate cancer 2023;International Journal of Urology;2024-07-30

3. Prediction of prostate cancer aggressiveness using magnetic resonance imaging radiomics: a dual-center study;Discover Oncology;2024-04-16

4. Biparametric MRI for Local Staging of Prostate Cancer: Current Status and Future Applications;Anticancer Research;2024-02

5. Dynamic Contrast-Enhanced Study in the mpMRI of the Prostate—Unnecessary or Underutilised? A Narrative Review;Diagnostics;2023-11-20